Article

Alcon, Advanced Medical Optics enter into IOL patent agreement

Huenenberg, Switzerland-Alcon Inc. and Advanced Medical Optics (AMO) have entered into a patent cross-licensing agreement relating to a specified one-piece IOL design and lubricious coatings for IOL insertion devices.

Huenenberg, Switzerland-Alcon Inc. and Advanced Medical Optics (AMO) have entered into a patent cross-licensing agreement relating to a specified one-piece IOL design and lubricious coatings for IOL insertion devices.

The agreement provides AMO with paid-up, non-exclusive, worldwide licenses restricted to single-piece IOLs having the same design as AMO’s recently launched IOL (Tecnis), according to a prepared statement issued by Alcon. The licenses assure AMO of freedom to operate with respect to the subject Alcon patents, relative to the launched IOL and any future IOL models having the same design platform. AMO will pay Alcon a lump sum of $10 million for those licenses, according to Alcon.

Additionally, Alcon will receive paid-up, non-exclusive, worldwide licenses under two families of patents owned by AMO, according to the statement. The licenses assure Alcon of freedom to operate with respect to the two patents, relative to the coating systems currently used in its IOL insertion devices (Monarch and AcrySert), as well as any future coating systems of a similar type that Alcon may develop. In the statement, Alcon said it will pay AMO a lump sum of $31 million for those licenses.

Other terms of the agreement were not disclosed.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.